Glycosyltransferases and non-alcoholic fatty liver disease

被引:0
|
作者
Yu-Tao Zhan [1 ]
Hai-Ying Su [2 ]
Wei An [3 ]
机构
[1] Department of Gastroenterology, Beijing Tongren Hospital, Capital Medical University
[2] Department of Cell Biology, Municipal Laboratory for Liver Protection and Regulation of Regeneration, Capital Medical University
[3] Department of Obstetrics and Gynecology, Shandong Jining First People’s Hospital
基金
中国国家自然科学基金;
关键词
Non-alcoholic fatty liver disease; Pathogenesis; Glycosyltransferases; Glycosylation;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
Non-alcoholic fatty liver disease(NAFLD) is the most common form of chronic liver disease and its incidence is increasing worldwide. However, the underlying mechanisms leading to the development of NAFLD are still not fully understood. Glycosyltransferases(GTs) are a diverse class of enzymes involved in catalyzing the transfer of one or multiple sugar residues to a wide range of acceptor molecules. GTs mediate a wide range of functions from structure and storage to signaling, and play a key role in many fundamental biological processes. Therefore, it is anticipated that GTs have a role in the pathogenesis of NAFLD. In this article, we present an overview of the basic information on NAFLD, particularly GTs and glycosylation modification of certain molecules and their association with NAFLD pathogenesis. In addition, the effects and mechanisms of some GTs in the development of NAFLD are summarized.
引用
收藏
页码:2483 / 2493
页数:11
相关论文
共 50 条
  • [1] Glycosyltransferases and non-alcoholic fatty liver disease
    Zhan, Yu-Tao
    Su, Hai-Ying
    An, Wei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (08) : 2483 - 2493
  • [2] Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
    Wu, Dongqing
    Zhu, Huaqing
    Wang, Hua
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [3] Non-alcoholic fatty liver disease and lipotoxicity
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 1 - 6
  • [4] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [5] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [6] Clinical approaches to non-alcoholic fatty liver disease
    Katherine JP Schwenger
    Johane P Allard
    World Journal of Gastroenterology, 2014, (07) : 1712 - 1723
  • [7] Gut microbiota and non-alcoholic fatty liver disease
    Gkolfakis, Paraskevas
    Dimitriadis, George
    Triantafyllou, Konstantinos
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (06) : 572 - 581
  • [8] A concise review of non-alcoholic fatty liver disease
    Than, Nwe Ni
    Newsome, Philip N.
    ATHEROSCLEROSIS, 2015, 239 (01) : 192 - 202
  • [9] Cytoskeleton alterations in non-alcoholic fatty liver disease
    Pessoa, Joao
    Teixeira, Jose
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128
  • [10] A Comprehensive Review on Non-Alcoholic Fatty Liver Disease
    Sahu, Prerna
    Chhabra, Pratyaksh
    Mehendale, Ashok M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)